FRED HUTCHINSON CANCER CENTER
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY
- Conditions
- Interventions
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT04060849
- Locations
- 🇺🇸
University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT03986502
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
- Conditions
- Interventions
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT03980769
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Conditions
- Interventions
- Radiation: Total-Body IrradiationDrug: ThiotepaDrug: FludarabineDrug: CyclophosphamideBiological: Peripheral Blood Stem CellDrug: TacrolimusBiological: Allogeneic CD34+-enriched and CD45RA-depleted PBSCsDrug: MethotrexateDrug: CyclosporineDrug: BusulfanDrug: SirolimusProcedure: Bone Marrow Aspiration and BiopsyProcedure: EchocardiographyProcedure: Multigated Acquisition ScanProcedure: Biospecimen Collection
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT03970096
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Glucosamine and Chondroitin in Gut in Preventing People From Inflammation
- Conditions
- Interventions
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2019-05-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT03963323
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
- Conditions
- Interventions
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 620
- Registration Number
- NCT03870750
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
🇺🇸Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
- Conditions
- Interventions
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT03864419
- Locations
- 🇺🇬
UCI-Fred Hutch Cancer Centre, Kampala, Uganda
Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients
- Conditions
- Interventions
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT03827161
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
- Conditions
- Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableRecurrent Acute Myeloid LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Myelodysplastic SyndromeAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmRecurrent Acute Biphenotypic Leukemia
- Interventions
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT03807063
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Reducing Insulin, Growth Hormones, and Tumors
- Conditions
- Interventions
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT03785808
- Locations
- 🇺🇸
Seattle Cancer Center Alliance, Seattle, Washington, United States